| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2012 | Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors | Chong-Jen Yu; Hsu, Chia-Lin; Chen, Kuan-Yu; CHIA-LIN HSU; CHAO-CHI HO; Shih, Jin-Yuan; JIN-YUAN SHIH; Ho, Chao-Chi; Yang, Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr | BMC Cancer | 54 | 55 |  |
| 2016 | Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review | Lin, Yen-Ting; Chong-Jen Yu; JIN-YUAN SHIH; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin; Shih, Jin-Yuan; Shih, Jin-Yuan | Clinical Lung Cancer | 15 | 17 | |
| 2016 | Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma | Wu, Shang-Gin; Chong-Jen Yu; Wu, Shang-Gin; Liu, Yi-Nan; JIN-YUAN SHIH; Yu, Chong-Jen; Yu, Chong-Jen; Yang, Pan-Chyr ; Yang, Pan-Chyr; Shih, Jin-Yuan; Shih, Jin-Yuan | JAMA Oncology | 11 | 13 | |
| 2014 | Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non-Small-Cell Lung Cancer | Lee, Jih-Hsiang; Lin, Yu-Lin; Hsu, Wei-Hsun; Chen, Hsuan-Yu; Chang, Yeun-Chung; Yu, Chong-Jen; Shih, Jin-Yuan; Lin, Chia-Chi; Chen, Kuan-Yu; Ho, Chao-Chi; Laio, Wei-Yu; Yang, Pan-Chyr; Yang, James Chih-Hsin | J. Thorac. Oncol. | | | |
| 2014 | Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non-Small-Cell Lung Cancer | Lee, Jih-Hsiang; Lin, Yu-Lin; Hsu, Wei-Hsun; Chen, Hsuan-Yu; Chang, Yeun-Chung; Yu, Chong-Jen; Shih, Jin-Yuan; Lin, Chia-Chi; Chen, Kuan-Yu; Ho, Chao-Chi; Laio, Wei-Yu; Yang, Pan-Chyr; Yang, James Chih-Hsin; 楊泮池 | J. Thorac. Oncol. | | | |
| 2009 | Bibw 2992, a Novel Irreversible Egfr/Her2 Tyrosine Kinase Inhibitor, in Chemonaive Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations | YANG, CHIH-HSIN; SHIH, JIN-YUAN | JOURNAL OF THORACIC ONCOLOGY | | | |
| 2012 | Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment | YIH-LEONG CHANG; Chung, Kuei-Pin; Chong-Jen Yu; Huang, Yen-Tsung; YEUN-CHUNG CHANG; Chang, Yih-Leong; KUEI-PIN CHUNG; Yu, Chong-Jen; JIN-YUAN SHIH; Yang, Chih-Hsin; Chang, Yeun-Chung; Shih, Jin-Yuan; Yang, Pan-Chyr | Chest | 34 | 37 | |
| 2014 | Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension | Lin, Mong-Wei; CHEN-TU WU ; YIH-LEONG CHANG; Wu, Chen-Tu; Shih, Jin-Yuan; JIN-YUAN SHIH; Chang, Yih-Leong; Yang, Pan-Chyr | Journal of Surgical Oncology | 22 | 20 | |
| 2016 | Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis | Chen, Li-Yang; Chen, Li-Yang; Chong-Jen Yu; Molina-Vila, Miguel A.; WEI-YU LIAO; KAI-LUN YU; Ruan, Sheng-Yuan; Ruan, Sheng-Yuan; Ruan, Sheng-Yuan; Su, Kang-Yi; Su, Kang-Yi; CHAO-CHI HO; KANG-YI SU; Liao, Wei-Yu; Liao, Wei-Yu; Yu, Kai-Lun; Yu, Kai-Lun; JIN-YUAN SHIH; Yu, Kai-Lun; Ho, Chao-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Shih, Jin-Yuan; Shih, Jin-Yuan; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin; Rosell, Rafael; Rosell, Rafael; Yang, Pan-Chyr ; Yang, Pan-Chyr; Yang, Pan-Chyr | Lung Cancer | 41 | 42 | |
| 2008 | Cytologically proven meningeal carcinomatosis in patients with lung cancer: Clinical observation of 34 cases | Chong-Jen Yu; JIN-YUAN SHIH; CHUANG, TZU-YI; Yu, Chong-Jen; SHIH, JIN- YUAN; YANG, PAN-CHYR; KUO, SOW-HSONG; SHIH, JIN-YUAN | Journal of the Formosan Medical Association | 25 | 22 | |
| 2015 | DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers | YIH-LEONG CHANG; Lin, Yun-Chieh; JIN-YUAN SHIH; Lin, Yu-Chin; Shih, Jin-Yuan; Huang, Wei-Jan; Chao, Shi-Wei; Chang, Yih-Leong; Chen, Ching-Chow | Clinical Cancer Research | 23 | 28 | |
| 2020 | The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation | SHANG-GIN WU ; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan | Therapeutic advances in medical oncology | | 0 | |
| 2008 | Effects of activating epidermal growth factor receptor mutations on clinical response | Gow, Chien-Hung; Chien, Chun-Ru; Chang, Yih-Leong; Chiu, Yueh-Hsai; Kuo, Sung-Hsin; Shih, Jin-Yuan; Chang, Yeun-Chung; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr | Clin Cancer Res | | | |
| 2012 | Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy | Chong-Jen Yu; Hwang, Chueh-Lung; Yu, Chong-Jen; JIN-YUAN SHIH; Shih, Jin-Yuan; Yang, Pan-Chyr; Wu, Ying-Tai | Supportive Care in Cancer | 62 | 74 |  |
| 2016 | Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations | Chen, Yen-Fu; MIN-SHU HSIEH; Hsieh, Min-Shu; YIH-LEONG CHANG; Wu, Shang-Gin; Chong-Jen Yu; Chang, Yih-Leong; JIN-YUAN SHIH; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan | Journal of Thoracic Oncology | 31 | 36 | |
| 2005 | Egfr Mutation Conferring Primary Resistance to Gefitinib in Non–Small- Cell Lung Cancer | YANG, PAN-CHYR; GOW, CHIEN-HUNG; SHIH, JIN-YUAN; 楊泮池 | THE NEW ENGLAND JOURNAL OF MEDICINE | | | |
| 2012 | EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR | YIH-LEONG CHANG; Wu, Shang-Gin; Kuo, Yao-Wen; Chong-Jen Yu; JIN-YUAN SHIH; Chang, Yih-Leong; Shih, Jin-Yuan; Chen, Ya-Hui; Tsai, Meng-Feng; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr; 陳盈憲 | Journal of Thoracic Oncology | 77 | 69 | |
| 2015 | Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis. | Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin | J. Clin. Oncol. | | | |
| 2015 | Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis. | Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin | J. Clin. Oncol. | | | |
| 2008 | First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer. | Wu, Jenn-Yu; Yu, Chong-Jen; Chih-HsinYang; Wu, Shang-Gin; Chiu, Yueh-Hsia; Gow, Chien-Hung; Chang, Yeun-Chung; Hsu, Ya-Chieh; Wei, Pin-Fei; Shih, Jin-Yuan; Yang, Pan-Chyr | American journal of respiratory and critical care medicine | | | |
